Embark offers dog DNA testing that ends preventable diseases in dogs.
Embark has raised $75.0M in total funding. The most recent round was Series B. The last funding was announced in July 2021.
Embark's investors include Slow Ventures, SV Angel, Founder Collective, FJ Labs, Freestyle Capital.
Embark is headquartered in Boston, United States.
Embark offers dog DNA testing that ends preventable diseases in dogs.
Embark is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Embark — Funding & Investors." VCBacked, July 26, 2021, https://www.vcbacked.co/company/embark. Accessed July 19, 2026.
VCBacked. (2021). Embark — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/embark
{{cite web |title=Embark — Funding & Investors |url=https://www.vcbacked.co/company/embark |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated